Senator Richard Blumenthal wants the Federal Trade Commission to investigate whether some drug companies are illegally withholding samples of brand-name drugs from generic manufacturers, driving up prices and limiting patient access...
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content
If you do not currently subscribe to FTCWatch please contact us for subscription information: